Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$ITMC One of the biggest reasons $ITMC makes a good investment is because of using smart contract blockchain folks.
The key functions that comprise this Smart Contract include, among others:
Adding Users to the blockchain as a combination of their hashed biometric public key and blockchain wallet address so that they can have immutable test results associated with them. A user must first be added before they can have immutable test results recorded for them. This combination hash is first submitted by the user using the mobile application and then processed by the administrative application.
Adding Verified Test Machines to the blockchain using their blockchain wallet address. A test machine must first be added by the administrative to the blockchain before it can write test results to blockchain.
Adding Immutable Test Results to the blockchain. An immutable test result consists of ...
Updating User details with testing status and latest test result
Getting Immutable Test Results and associated details
$MCTC nice Tweet out: https://twitter.com/CannabisGInc/status/1265344147973705734?s=19
$SGMD and BudCars 15% increase week over week.
Suagarmade announces #Budcars delivery of our top shelf #Cannabis products at a steady increase of 15% week over week. We’ll be updating our $SGMD shareholders w/the announcement of our next city in the coming days! Order your favorite #CBD #THC #edibles & more! 877-Bud-2-You! pic.twitter.com/2lokUo5882
— Sugarmade Inc (OTC:SGMD) (@Sugarmade1) May 22, 2020
On radar: $PASO, $MCTC, $CODX, $SGMD, $NUGS
$SGMD nice hits coming in at .0029, .003 break coming soon.
Loving this $SGMD TWEET:Sugarmade Inc (OTCQB:SGMD)
@Sugarmade1 Good morning. As we prepare to update our $SGMD shareholders on our business growth, SugarMade Inc. Is proud to announce #Budcars #revenue has spiked to an all time high once again forcing a larger #expansion then previously planned. Updates on the way. #BusinessGrowth #Cannabis
AVVH$$$$ PATIENCE ALWAYS WINS AND PAYS BIG DIVYS UPDATES PENDING
AVVH$$$ LOAD AND HOLD
NEWS IMMINENT
https://twitter.com/AvvaaWorld?
BIG BOLD BUY RATING
https://www.barchart.com/stocks/quotes/AVVH/opinion
http://www.allotcbb.com/quote.php?symbol=AVVH
BOTTOM IS IN
https://www.stockscores.com/charts/charts/?ticker=avvh
TINY SS AND THIN
https://www.otcmarkets.com/stock/AVVH/security
Strong PR $IMIMF Yesterday, Half Mil Placement: IMC International Mining Corp. Announces Flow-Through Share Brokered Private Placement of up to $500,000 Led by Gravitas Securities and Exercise of Agents' Option on Previously Announced Brokered Unit Financing
ACCESSWIRE ACCESSWIRE•May 4, 2020
VANCOUVER, BC / ACCESSWIRE / May 4, 2020 / IMC International Mining Corp. (CSE:IMCX)(OTC PINK:IMIMF)(FRA:3MX) (the "Company" or "IMC") is pleased to announce a brokered private placement of up to 769,230 common shares of the Company issued on a flow-through basis (each, a "Flow-Through Share") at a price of CAD$0.65 per Flow-Through Share (the "Issue Price") for gross aggregate proceeds of up to CAD$500,000 (the "Offering").
The Company is also pleased to announce that the Agents (as defined below) to the Company's brokered private placement of units of the Company (each, a "Unit") announced on April 27, 2020 (the "Unit Offering") intend on exercising their option to increase the size of the Unit Offering.
Brokered Flow-Through Share Private Placement
The Company has entered into an agreement with Gravitas Securities Inc. whereby it will act as lead agent (the "Lead Agent"), on its own behalf, and if applicable, on behalf of a syndicate of agents (collectively with the Lead Agent, the "Agents"), pursuant to which the Agents will act on behalf of the Company to sell, on a best efforts basis, up to 769,230 Flow-Through Shares at a price of CAD$0.65 per Flow-Through Share for gross aggregate proceeds of up to CAD$500,000.
In connection with the Offering, the Company has granted the Agents an option (the "Agents' Option"), exercisable in whole or in part at any time up to two days prior to the last closing date of the Offering, which will allow the Agents to increase the Offering by up to an additional 2,307,692 Flow-Through Shares, for additional gross aggregate proceeds of up to CAD$1,500,000, and otherwise on the same terms as the Offering.
An amount equal to the gross proceeds from the issuance of the Flow-Through Shares will be used for "Canadian exploration expenses" that will qualify as "flow-through mining expenditures", as defined in the Income Tax Act (Canada). The Company will renounce to the subscribers of the Flow-Through Shares effective as of December 31, 2020 an amount of Canadian exploration expenses that will qualify as flow-through mining expenditures equal to the gross proceeds from the sale of Flow-Through Shares.
The Agents will also be entitled to a cash fee in an amount equal to 8% of the cash proceeds received from the sale of Flow-Through Shares, and to broker warrants (each, a "Broker Warrant") in an amount equal to 8% of the number of Flow-Through Shares sold pursuant to the Offering. Each Broker Warrant will entitle the holder to acquire one common share of the Company (each, a "Common Share") at any time for a period of two years from the date of issuance thereof at an exercise price of $0.70 per Common Share. The Broker Warrants are subject to accelerated expiry if the volume weighted average closing price of the Common Shares on the Canadian Securities Exchange is equal to or greater than CAD$0.88 for a period of ten consecutive trading days, in which case the Company will have the option, but not the obligation, to accelerate the expiry to 20 days from the date of notice.
The securities to be issued under the Offering will be subject to a hold period of four months and one day from the date of issue in accordance with applicable Canadian securities laws.
Exercise of Agents' Option
The Company is also pleased to announce that the Agents, who also act as agents to the Company's Unit Offering, intend on exercising their option to increase the Unit Offering. In connection with the Unit Offering, the Agents agreed to act on behalf of the Company to sell, on a best efforts basis, up to 2,083,333 Units at a price of CAD$0.48 per Unit for gross aggregate proceeds of up to CAD$1,000,000. In connection with the Unit Offering, the Company granted the Agents an option (the "Agents' Unit Option") exercisable in whole or in part at any time up to two days prior to the closing of the Unit Offering, which will allow the Agents to increase the Unit Offering by up to an additional 2,083,333 Units, for additional gross aggregate proceeds of CAD$1,000,000, and otherwise on the same terms as the Unit Offering. The Company understands that the Agents intend on exercising the Agents' Unit Option.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
ON BEHALF OF THE BOARD OF DIRECTORS
Brian Thurston
Chief Executive Officer and President
ABOUT INTERNATIONAL MINING CORP.
IMC is a junior exploration and development company. It is focused on creating shareholder value through the advancements of its assets which include the Cathedral Property in Northern British Columbia and the Bullard Pass Property in Arizona. The Company continues to look for further assets in North & South America as it increases its asset portfolio. IMC will utilize its heavily experienced management team to evaluate assets that provide shareholder value.
IMC continues to evaluate additional properties to add to its portfolio of mining assets.
INVESTOR RELATIONS:
ir@internationalmining.ca
1 (604) 588-2110
https://imcxmining.com
$MCTC looking like a steal. Anything under 40 cents there is a no brainer.
$NUGS hovering at dime break. Great entry.
$MCTC THC-V tech breakthrough- Smart trade. moving up past the .30 break. Looking thin to go higher.
Algernon $AGN $AGNPF Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
https://globenewswire.com/news-release/2020/04/29/2024542/0/en/Algernon-Receives-Clearance-from-Health-Canada-for-Ifenprodil-COVID-19-Phase-2b-3-Multinational-Clinical-Trial.html
Blueprint Medicines $BPMC Set to Announce Quarterly Earnings on Wednesday http://americanbankingnews.com/?p=14336887 #stocks
$VERB Begins Japan Operations as Part of International Expansion Plan Tapping into a Multi-Billion-Dollar Market Opportunity
https://globenewswire.com/news-release/2020/04/28/2023264/0/en/VERB-Begins-Japan-Operations-as-Part-of-International-Expansion-Plan-Tapping-into-a-Multi-Billion-Dollar-Market-Opportunity.html
$UAVS “Working with a Large eCommerce Company on a 3-Year Agreement to produce their early package delivery system”... You heard it from the horses mouth...
-
These Are the Candidates for Partners: $AMZN $GOOGL $BABA
-
Even if it doesn’t turn out to be Amazon, this will be BIG!
$VISL , $UAVS, $NNDM , $MARK, $XELA dips. Adding time
$ACRL at .004
$ALPP at .0438
$FONU at .0007
$GRNF at .1745
$GTCH at .0185
$IGEN at .0007
$MVNT at .0101
$TOMI at .0485
$RMSL at .0062
$TPTW at .0014
My portofolio
$SGMD nice research report - outlines nicely their market and potential future revenue growth. Solid growth plans in hot sector not on many investors radar right now - won’t be long
http://www.otcmarkets.com/financialReportViewer?symbol=SGMD&id=244757
$GRSO Record volume. Volume precedes price.
Still near 52 wk lows, big move coming.
$OZSC $GRNF $VRUS $GRSO $INQD So far it’s been an exciting two days! Loaded and ready to make some money.
$PLYZ BABBBBY what a find.....
https://plyzertechnologies.com/2020/03/plyzer-technologies-spain-sl-signs-vitae-health-innovation-as-a-new-saas-customer-for-its-business-analytics-platform-plyzer-intelligence/
https://plyzertechnologies.com/2020/03/plyzer-technologies-spain-sl-signs-the-global-life-science-company-bioiberica-as-a-new-saas-customer-for-its-business-analytics-platform-plyzer-intelligence/
https://plyzertechnologies.com/2020/03/plyzer-technologies-spain-sl-signs-pharmaceutical-chiesi-spain-as-a-new-saas-client-for-its-business-intelligence-platform-plyzer-intelligence/
THE DD CONTINUES...
$CBDL .0017 HOD +16% starting. Hand Sanitizer + CBD Products + Hemp Products = HUGE.
$KOSK huge potential on this #CBD play. #Cannabis stocks have been trending.
$KOSK .0033s up now. Bottom confirmed. A lot thinner today after yesterdays loading to .0035s. Watch for the break here.
Some of todays most active stock options 4.27.20 $TSLA $NFLX $TLRY
$BLIS has put out some big news recently!
https://otcmarkets.com/stock/BLIS/news
$ILAL BIG PR- 44 units at Plaza Bajamar https://finance.yahoo.com/news/international-land-alliance-announces-affordable-120010552.html
$MCTC & BUDCARS = Powerful Agreement! Cannabis Global Inc. Is proud to announce that we will be updating our $MCTC shareholders this week on our product license agreement for #Cannabis #Edibles w/ #Budcars the fastest growing delivery service in California as well as our corporate progression. #420allmonth #Hemp
Cannabis Global Inc. Is proud to announce that we will be updating our $MCTC shareholders this week on our product license agreement for #Cannabis #Edibles w/ #Budcars the fastest growing delivery service in California as well as our corporate progression. #420allmonth #Hemp pic.twitter.com/iFkyDrdx9Y
— CannabisGlobalinc (@CannabisGInc) April 27, 2020
MORE NEWS COMING $NUGS Good morning Cannabis Strategic Venture OTC: $NUGS shareholders! We are working diligently on the launch of our newest #cannabis brand, stay tuned for updates on the launch & many more exciting updates coming this week! #StaySafeStayHealthy! #MondayVibes #420allmonth #covidsafe
Good morning Cannabis Strategic Venture OTC: $NUGS shareholders! We are working diligently on the launch of our newest #cannabis brand, stay tuned for updates on the launch & many more exciting updates coming this week! #StaySafeStayHealthy! #MondayVibes #420allmonth #covidsafe pic.twitter.com/JRwJKElQ6N
— Cannabis Strategic Ventures, Inc. (@NUGS_stock) April 27, 2020
$AGNPF NEW CSO! #AlgernonTeam: Meet our CSO, Mark Williams! #AlgernonTeam: Meet our CSO, Mark Williams!
His innovative approach to drug discovery led to the creation of our #DrugRepurposing business model that has high capital efficiency and strives to deliver maximum value to shareholders: https://bit.ly/39OtBoP
His innovative approach to drug discovery led to the creation of our #DrugRepurposing business model that has high capital efficiency and strives to deliver maximum value to shareholders: https://t.co/m48pFlb4nn$AGN.CN $AGW $AGNPF pic.twitter.com/V7h34nrr8X
$OZSC debt purchase agreements are being finalized, and evidence suggests debt lockup very soon.
$OZSC watching for DPA to become finalized over the next week = then watch the peeps jump on board - we will be heading back over .10
$GTBP - GT Biopharma up 20% on plan for coronavirus treatment https://seekingalpha.com/news/3550190-gt-biopharma-up-20-on-plan-for-coronavirus-treatment?utm_campaign=twitter_automated&utm_content=news&utm_medium=social&utm_source=twitter_automated
$IMIMF gold is the safe haven we need here in this volatile market.
$AGNPF Nice PR yesterday: Algernon Receives Regulatory and Ethics Approval for Phase 2 Ifenprodil COVID-19 Human Study in South Korea
GlobeNewswire GlobeNewswireApril 23, 2020
VANCOUVER, British Columbia, April 23, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE:AGN) (AGW.F) (AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has received approval from the Ministry of Food and Drug Safety in South Korea, as well as ethics approval, for an investigator-led, Phase 2 COVID-19 clinical study of its re-purposed drug NP-120 (Ifenprodil), an NMDA receptor antagonist.
The Lead Principal Investigator is Dr. Dong Sik Jung, Professor, in the Division of Infectious Disease of Dong-A University Hospital, Busan.
The 40-patient, 4-week trial, is designed to test the effect of Ifenprodil in COVID-19 infected patients with severe pneumonia. Patients are randomized in a 1:1 fashion to receive either standard of care (SOC) or SOC with Ifenprodil. The primary endpoint will be the rate at which their lung function improves by measuring oxygen levels in the blood (Pa02/Fi02). Secondary endpoints will include mortality, rate of mechanical ventilation, and patient reported effects on cough and breathlessness (dyspnea).
Enrollment in the phase 2 clinical trial is expected to begin on May 8, 2020.
“This first human trial of Ifenprodil in COVID-19 patients is a major step forward with our new acute lung injury clinical research program,” said Christopher J. Moreau CEO of Algernon. “Positive Phase 2 data would be an important milestone as we continue to investigate Ifenprodil’s therapeutic potential as a treatment for COVID-19, in addition to advancing our idiopathic pulmonary fibrosis and chronic cough program.”
The Company cautions that while it is preparing to begin a Phase 2 clinical trial shortly in South Korea, it is not making any express or implied claims that NP-120 (Ifenprodil) is an effective treatment for acute lung injury (ALI), the COVID-19 virus, or any other medical condition at this time.
About NP-120 (Ifenprodil)
NP-120 (Ifenprodil) is an N-methyl-D-aspartate (NMDA) receptor antagonist specifically targeting the NMDA-type subunit 2B (Glu2NB). Ifenprodil prevents glutamate signalling. The NMDA receptor is found on many tissues including lung cells and T-cells, neutrophils.
The Company believes NP-120 can reduce the infiltration of neutrophils and T-cells into the lungs where they can release glutamate and cytokines respectively. The latter can result in the highly problematic cytokine storm that contributes to the loss of lung function and ultimately death as has been reported in COVID-19 infected patients.
About Algernon Pharmaceuticals Inc.
Algernon is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.
Algernon has filed new intellectual property rights globally for NP-120 (Ifenprodil) for the treatment of respiratory diseases and is working to develop a proprietary injectable and slow release formulation.
CONTACT INFORMATION
Christopher J. Moreau
CEO
Algernon Pharmaceuticals Inc.
604.398.4175 ext 701
info@algernonpharmaceuticals.com
investors@algernonpharmaceuticals.com
www.algernonpharmaceuticals.com
$NUGS Tweet:
Cannabis Strategic Ventures is working around the clock to fill our huge backlog of orders, several 1000s of pounds in PO’s for the #Cannabis community & are in the final stages of our own $NUGS brand launch! Exciting days on the way! #StayHome #StaySafe #420allmonth pic.twitter.com/pJyipbZjES
— Cannabis Strategic Ventures, Inc. (@NUGS_stock) April 24, 2020
Nice open on $IGEN, $XALL, $VMSI, $CHK
$SXTC looking gooood with its momentum kicking up here.
$IGEN Receives Sprint IoT Factory Order to Manage Ride-Share Leased Vehicles with the first 500 vehicles to be activated in the Tri-State Area of New York. Sprint confirmed market trials and orders from Puerto Rico, Southern California and the Mid-West Regions
Roll-up of Nimbo LLC into iGen as well.
Imagine what he is waiting to release for first quarter 2020 (especially with the Sprint deal), which goes back to my theory of all the Form 4's.
$CBDL .0015 CBD-Infused Hand Sanitizer + Hemp + CBD Products = BOOM!
Followers
|
30
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
153
|
Created
|
04/17/12
|
Type
|
Free
|
Moderator MikeyLikesStocks | |||
Assistants |
Big 5 allows readers to get a quick summary of the hottest OTC stocks trading today. Don't take a shot in the dark, just one visit to the BIG 5 allows you to scan through myriads of companies to see what's hot and what's not.
Tell us about your pick in summaries of 5 or less number or bullet points.
Time is of the essence and BIG 5 is here to save you a ton of time. We are the "executive summaries" of IHUB boards!
So please share you BIG 5!
"My BIG 5 for $ABCD company:
1. Experienced Leadership
2. Good Float-No Dilution!
3. 40% Inside Investors
4. Growing market place with a 60% increase in customer growth
5. Solid buisness plan going forward.
CHECK out $ABCD!"
1. Summarize please. Paragraphs of text hurts our eyes.
2. Charts, PRs, and Tweets are acceptable.
3. Price targets are A-OK.
4. Feel free to share web links.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |